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Abstract: The purpose of this study is to make a comparison between the patentable subject matter in French and 
Jordanian law in order to extract the similarities and differences to establish basic principles for Palestine. The Jordanian 
law is selected as it is in general the law that is applied in Palestine. 
Palestine is the only country in the Middle East that does not have legislations protecting intellectual property rights. 
However, there are sporadic laws applied in Palestine, such as the Ottomans’ law in 1910 related to copyright law and 
the Jordanian trademark 1952 and patent law in 1953. In 1995 the Palestinian Authority approved some legislation in the 
field of private law, such as civil and commercial law, but without including in it intellectual property legislation. The term 
intellectual property is not popular among Palestinian legislators as there are among them few experts in this field. 
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I. INTRODUCTION 
In French law, there is no precise definition of the 
term invention. In contrast to the Jordanian law which 
define it in Article 2 as “any invention idea reached by 
an inventor, in any of the fields of technology, which is 
related to a product, or a process, or to both which 
provides a practical solution to a particular problem in 
any of the said field”. (Jordan Patent law, 1999). 
The current trend in both legislation French and 
Jordanian similar to TRIPS agreement confirm that: an 
invention must meet several criteria if it is to be eligible 
for patent protection. Firstly the invention must be 
industrially applicable, then it must be new (novel), and 
finally it must exhibit a sufficient “inventive step”.( 
Art.27 of Trips agreement, 1995). 
Nonetheless, the European Patent Convention and 
both the French and Jordanian law, excludes the 
Following classes from its definition of “invention”: 
- Discoveries, scientific theories and mathematical 
methods;  
- Aesthetic Creations;  
- Schemes, Rules and Methods for performing 
mental acts, playing games or doing business,  
- Methods of treatment for humans or animals, or 
diagnostic methods practiced on humans or 
animals  
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- Programs for computers; (Article 52 of European 
patent Convention, 1973) 
II. DISCOVERIES 
Whether in French or in Jordanian law, discoveries 
have been regarded as outside the scope of patentable 
subject matter because it does not have the character 
of a creation.  
Regarding Nicolas Bouche (2014): "a discovery 
consists of establishing a phenomenon which existed in 
the nature, but was unknown. It is unpatentable as 
such, but the industrial applications of a discovery may 
be patented. Whereas what characterizes the invention 
is that it is voluntary coordination by human material 
resources (Luc, 2003).  
On other words, it’s the laws of nature, physical 
phenomena and abstract ideas. Therefore, discoveries 
often lead to practical inventions, and those inventions 
are patentable (Mousseron, 1984). 
According to Professor Binctin ( 2007), this 
exclusion is due to the fact that "the intellectual effort is 
not in question, regardless of the difficulties 
encountered in reaching the discovery, it is always the 
identification of a natural state and not a 
creation.”(Binctin, 2007). However, if it is a natural 
substance that is produced by a technical effect, it may 
be patentable, only for its technical effect.  
Any human intervention that allows making the 
distinction is a measure of patentability (Dulian, 1999). 
Since this human intervention occurs either at the 
creation of the product, or that of his application. Thus, 
the discovery of a natural product can result in patent 
Comparison between French and Jordanian Laws International Journal of Humanities and Social Science Research, 2015 Vol. 1      103 
protection (Lamy 2000). However, since the product is 
not found obviously in nature and its creation involves 
human intervention, it may be in the presence of a 
patentable invention. This is particularly the case of the 
products obtained by fermentation of a microorganism 
(Vivant, 2005). 
The French case law has confirmed the non-
patentability of the discovery by a judgment of the 
Supreme Court on 7 February 2007. The High Court of 
Paris in the case “Institut Pasteur v Chiron Blood 
Testing,” stated that; “a virus was not patentable in 
itself but that all or part of its genome was patentable 
inasmuch as it enables the manufacture of a product 
used for diagnosis or treatment” (HCP, Institute 
Pasteur, 2007). 
The ultimate result that the researcher disagree to 
consider that the discoveries outside the scope of 
patentable subject matter of the Jordanian and French 
legislators as well the international agreements should 
start deeply thinking to protect the discoveries due to 
its a result of human effort.  
III. AESTHETIC CREATIONS 
Both French and Jordanian laws exclude the scope 
of patentability in "aesthetic, artistic creations." They 
are protected may be under the copyright laws if it’s 
origin, e.g. (painting, sculpture, etc). Such exclusions 
might seem unfortunate at a time when aesthetics 
develop in the field of manufacture of utilitarian objects. 
This is because the patent in French law allows 
ownership of a function, not form. The aesthetic choice 
of designer is indifferent. However, if the aesthetic form 
is excluded from patentability, a patent may cover 
technical means used to obtain this form, or technical 
structures that create the aesthetic effect. Therefore, 
we retain complete independency between the means 
used to achieve aesthetic creations and the result 
(Binctin, 2007). 
The Board of Appeal of the European Patent Office 
(EPO) summarized this way:  
“In T 686/90 the board was called upon to 
decide whether the feature "work of art in 
the style of stained glass" meant that it 
was excluded from patentability under Art. 
52(2)(b) EPC 1973. The board held that 
functional information referring to general 
aesthetic creations did not define an 
aesthetic creation as such, at least 
provided that and insofar as such 
information adequately identified technical 
features of the subject-matter of the claim. 
Since an aesthetic creation (not formally 
specified) as the stated purpose, together 
with the other features, adequately defined 
a technical subject-matter in the claim, 
there was no aesthetic creation as such. 
For this reason there could be no 
objection to the claim under Art. 52(2)(b) 
EPC 1973 on the basis of Art. 52(3) EP 
1973 (EPO, 1973). 
IV. SCHEMES, RULES AND BUSINESS METHODS  
French and Jordanian law, scientific theories, and 
mathematical methods are also excluded from the 
scope of protection. Furthermore, French law has 
added another measure of exclusion for "schemes, 
rules and methods for performing mental acts, playing 
games, or in doing business.” Schemes, rules and 
methods for performing mental acts have "abstract" 
and not industrial applications (Becquet, 2005).  
A simple idea has never been appropriate. This is a 
very general rule that also applies in literary and artistic 
property. One cannot legitimately protect the concrete 
of an idea, nor the abstract idea accomplishments 
(Dulian, 1999). 
Thus, when the alleged invention solves an 
economic problem, not a technical, then it is a 
commercial method is not patentable, unimportant it 
uses technical means to solve this problem of non-
technical. This is what was decided by the Court of 
Appeal of Paris in a judgment of 15 March 2006 (PIBD, 
2006). 
Regarding the business method, Article L.611-10, 
paragraph 2, 3, (French property code) has confirmed 
the exclusion of business methods. It stated that: “1. 
Inventions which are susceptible of industrial 
application, which are new and which involve an 
inventive step shall be patentable.2. The following in 
particular shall not be regarded as inventions within the 
meaning of the first paragraph of this Article: a) 
discoveries, scientific theories and mathematical 
methods; b) aesthetic creations; c) schemes, rules and 
methods for performing mental acts, playing games or 
doing business, and programs for computers; ........”.  
However, in the United States of America, it is 
possible to grant patents for the "Business Method". 
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The Business Method are all methods used in direct 
contact between a company and its customers as well 
as any method that allows a business to run, both 
internally and in its relations with third parties ( WIPO, 
2014). We argue that the patentability of business 
methods was confirmed by US court of appeals in 1998 
decision; it stated that “a mathematical algorithm is not 
excluded from patentability if it produces a useful, 
concert and tangible result” (CAFC, 1998).  
The challenge is to distinguish the method is not a 
patentable process that is perfectly fine. The criterion is 
that the abstraction of the first opposed to the industrial 
character of the second. The method results in an 
abstract intellectual result as the process leading to an 
industrial result that materializes in a technical effect or 
product. This explains why we link exclusion methods 
to lack of industrial character (Galloux and Azema, 
2006). 
However, exceptions which appear to diminish the 
rule exist for both software and business-related 
inventions, so long as they are seen as addressing 
technical problems: both the EPO and France make 
patentability determinations on the basis of “technical 
contribution” (Dulian, 1999). 
In Jordan, Article L.4 patent law also excludes 
business methods from protection, so that commercial 
exploitation is useful for the protection of life, human 
health, animals, or plants to avoid serious 
environmental damage. 
The evidence presented in this research that the 
Jordanian law restricts the exclusion of Business 
method in particularly to the issue which makes impact 
on the life, contrary to French law which keeps it 
extensively. 
V. COMPUTER PROGRAMS 
In French law, the articles 511-1 and 611-10 of the 
Code of Intellectual Property and Article 52 EPC 
computer programs differ in their scope. Yet, this 
exclusion appears to contradict Article 27§3 of TRIPS. 
Computer programs can be protected through 
copyright law as stated in Article L112-2, 13 of the 
Code of Intellectual Property. 
Professor Joanna Schmidt (2012) defines a 
computer program as a set of instructions expressed in 
a specific form and sent to a computer for a specific 
result. The software is the product of an intellectual 
activity expressed in a particular language that 
responds to the idea of creation of form. Every 
programmer expresses his personality in how to write 
the program, making personal choices (Caillaud, 2003). 
The reasons for this exclusion are multiple. First, 
they take the particularism of this kind of creation that 
lead to technical difficulties in the implementation of 
patent protection (meeting the requirements of an 
industrial character, novelty and inventive step above, 
formulation of claims, appreciation counterfeiting 
(Dulian, 1999). 
Second, difficulties arise relating to the disclosure 
requirement of the invention. The technique of the 
patent requires full disclosure of the invention, 
therefore, to describe the program so that "the art" 
could reproduce with only basic knowledge. However, 
the section 611-10.3 of the Code of Intellectual 
Property shall apply to inventions whose software is 
only one component. Software are not a patentable, 
however, a technical invention which involves software 
is patentable. 
The French courts have upheld this rule by a 
judgment of Court of Appeal of Paris on 15 June 1981: 
"If computer programs are in principle excluded from 
patentability, a method may be deprived of patentability 
for the sole reason that one or more of these steps are 
performed by a computer to be controlled by a 
program" (Mathély, 1982). 
Regarding the position of the European Patent 
Office (Lucas, 1990). The EPO case law has confirmed 
the non-patentability of the software by a judgment of 
the board of appeal on 5 March 2002 stated that: 
“information modelling is in principle a non-technical 
activity, and only a purposive use of information 
modelling in the context of a solution to a technical 
problem may contribute to the technical character of an 
invention.  
The Board considers that the claimed connection 
with CAD/CAM activities cannot qualify as such a 
purposive technical use. The product data-model does 
not enable, improve, or otherwise contribute to the 
solution of a concrete technical problem. The features 
defining the "product data-model" hence are non-
technical. This means that they cannot contribute to an 
inventive step. Since the mere additional mention of 
unspecified CAD/CAM activities and the feature 
specifying that the product data-model is "stored in a 
memory associated with a computer" cannot support 
an inventive step either, the invention as defined by 
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claim 1 lacks an inventive step within the meaning of 
Articles 52(1) and 56 EPC over a notorious general 
purpose computer. (...) "(EPO, 2014). 
Concerning the principle of cumulative protection by 
both copyright and the industrial property law, 
excluding the explicit exclusion, this combination 
should be possible for programs, computers, or 
software (Binctin, 2007). 
Indeed, the EPO and the European Commission 
wanted to remove the explicit exclusions for the 
exercise of various intellectual property rights on 
computer programs. However, this reform has failed 
twice before the European Parliament (EC, 2014). 
The Jordanian patent law does not mention the 
computer programs in the list of areas enjoying 
protection. The computer program may like the French 
law to be protected by copyright filed. 
The research suggests that the Jordanian patent 
law through its upcoming reform should continue 
protecting computer programs within the scope of 
copyright. At variance from the United States Law 
which includes the protection of computer programs 
within patent law similar to the European Union efforts 
to apply US patent law. Since protecting computer 
programs within the scope of copyright enables the 
author to obtain a longer protection in terms of 
duration.  
VI. METHODS FOR TREATMENT OF THE HUMAN 
OR ANIMAL BODY BY SURGERY OR THERAPY 
AND DIAGNOSTIC METHODS 
Methods for treatment of the human or animal body 
by surgery or therapy and diagnostic methods are not 
regarded as inventions susceptible of industrial 
applications (Lestanc, 2009).  
Article L611-16 of French intellectual property code 
and (Art. 53 EPC) provides that “methods for treatment 
of the human or animal body by surgery or therapy and 
diagnostic methods practiced on the human or animal 
body shall not be regarded as inventions susceptible of 
industrial application within the meaning of Article 
L611-10. This provision shall not apply to products, in 
particular substances or compositions, for use in any of 
these methods." Therefore this exclusion is largely 
based on public interest, public health and ethical 
considerations (Galloux, 2006). 
The medical procedures cannot be appropriated by 
the patent; however, the secret can sometimes allow 
reserving them. Jordanian law, meanwhile, did not 
address the topic of methods for surgical or therapeutic 
treatment of the human body. This may be because of 
the sensitivity of the subject, the Muslim religion; and 
customs of Jordan considering the human body as 
sacred. 
VII. PLANT VARIETIES 
Patent law in France has been reluctant to host 
organic or vegetable creations in its protection. Plant 
varieties eventually become an ad hoc regime defined 
and organized by the law of 11 June 1970, which 
created a title specific property: the plant breeders' 
rights (VOCs). 
UPOV (Union for the Protection of New Varieties of 
Plants) came into force in 1968, as revised at Geneva 
in 1972, 1978 and 1991, ratified by France on 
November 10, 1972 , and by Jordan on September 24, 
2004. It defines the varieties plant in Article 1, 
paragraph 6 stated that:  
"variety means a plant grouping within a single 
botanical taxon of the lowest known rank, which 
grouping, irrespective of whether the conditions for the 
grant of a breeder's right are fully met, can be 
- defined by the expression of the characteristics 
resulting from a given genotype or combination 
of genotypes, 
- distinguished from any other plant grouping by 
the expression of at least one of the said 
characteristics and 
- considered as a unit with regard to its suitability 
for being propagated unchanged; " 
Under French law, plant varieties are excluded from 
patent protection. This exclusion is explained today by 
specific protection regime established in Article 623-1 
of the French intellectual property law: 
“For the purposes of this chapter, "new plant 
variety" shall mean any new plant variety, whether 
created or discovered which:  
1. Is different from similar already known varieties 
by one characteristic that is important, precise 
and subject to little fluctuation or by several 
characteristics the combination of which is such 
as to give it the status of a new variety;  
2. Is homogenous in its characteristics;  
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3. Remains stable, that is to say identical with its 
original definition at the end of each cycle of 
multiplication”. 
Regarding the duration of protection, it’s twenty five 
years from its issue. For forest, fruit trees or 
ornamental vine for as well as perennial forage grasses 
and legumes, potatoes and inbred lines used for the 
production of hybrid varieties, the term of protection is 
thirty years .  
Likewise, Jordanian law, like the French excludes 
from protection patenting plant varieties. The Jordanian 
Parliament created a new a specific measure in 2000, 
"the law of plant breeders”, which protecting creations 
in agriculture field. The plant variety certificate is issued 
by the Jordanian Ministry of Agriculture in the Plant 
Variety department.  
Regarding the duration of protection, the article 18 
of the Jordanian law resembles, with the same rules as 
in Article L.19 of the UPOV Convention” The said 
period shall not be shorter than 20 years from the date 
of the grant of the breeder's right. For trees and vines, 
the said period shall not be shorter than 25 years from 
the said date”. 
The Jordanian law, in Article L.5 posed four 
conditions necessary to qualify for the protection 
afforded to plant varieties:  
• The novelty; 
• The distinctive character, which is that which 
distinguishes a variety of other varieties of the 
same species;  
• The homogeneity criterion, which is that of a 
likeness or resemblance between the individuals 
who compose it, that is to say, the existence of a 
large number of characteristics common to all 
plants variety;  
• The requirement of stability, which controls a 
variety for which protection is asked for is stable 
in its essential character, that is to say, it 
remains true to its description after repeated 
propagation or successive. 
For foreigners living in France or Jordan, the UPOV 
Convention provides that all foreigners who’s country 
signs the UPOV Convention, can get a plant variety 
certificate (VOCs) under the same conditions as 
French or Jordanian (Article 623-6, of French 
intellectual property code, 1992). 
CONCLUSION 
This research draws principally from the 
understanding that a patent is a right granted to the 
owner of an invention, which is a product or a process 
that provides a new technical solution to a technical 
problem. Narrowly, the inventions of a technical 
character are taken into account for patent protection; 
hence the discoveries, aesthetic creations, business 
method, methods of treatment for humans or animals, 
or diagnostic methods practiced on humans or animals, 
and software are not patentable. 
After having made the comparison between the 
Jordanian and French patent law, the research 
demonstrates that there are several similarities 
between both countries, since both systems apply 
international patent agreements in their national 
legislative.  
The researcher have chosen Jordan as a model to 
offer a solution for the establishment of an effective 
legal system for Patent rights in Palestine since the 
majority of the law and regulations of my country, 
(Palestine), are based on Jordanian law. The 
recognition of Palestine on November 29, 2012 as a 
non-member observer state in the UN allows Palestine 
to be a member of all United Nations agencies, 
including the WIPO, to benefit from IP protection at the 
international level. As consequences the Palestinian 
legislator should start seriously thinking about creating 
a Palestinian intellectual property code 
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